scholarly journals CLINICAL IMPORTANCE AND INTERDEPENDENCE OF PERIODIC BREATHING DURING ASLEEP AND EXERCISE IN PATIENTS WITH HEART FAILURE

2010 ◽  
Vol 55 (10) ◽  
pp. A34.E324
Author(s):  
Yoshitaka Oda ◽  
Shuji Joho ◽  
Daisuke Harada ◽  
Tadakazu Hirai ◽  
Hiroshi Inoue
2009 ◽  
Vol 15 (6) ◽  
pp. S26
Author(s):  
Lyle J. Olson ◽  
Adelaide M. Arruda-Olson ◽  
Jennifer M. Fitz-Gibbon ◽  
Bruce D. Johnson

2016 ◽  
Vol 55 (8) ◽  
pp. 1189-1198 ◽  
Author(s):  
Tieh-Cheng Fu ◽  
Wen-Chen Lin ◽  
Jong-Shyan Wang ◽  
Chao-Hung Wang ◽  
Chun-Tien Chang ◽  
...  

2019 ◽  
Vol 47 (12) ◽  
pp. 6294-6302
Author(s):  
Baojian Zhang ◽  
Biao Li ◽  
Fen Qin ◽  
Fan Bai ◽  
Chao Sun ◽  
...  

Objective This study was conducted to investigate the level of microRNA-155 (miRNA-155) in patients with heart failure (HF) after myocardial infarction (MI) and its clinical importance. Methods Serum miRNA-155 levels were measured using quantitative reverse transcription (qRT)-PCR. The left ventricular ejection fraction (LVEF), left ventricular posterior wall thickness, and left ventricular end-diastolic diameter were measured by echocardiography. Serum amino-terminal pro-B-type natriuretic peptide (NT-proBNP) and other parameters were also analyzed. Results miRNA-155 levels in patients with HF were significantly higher than in control and MI groups. The area under the receiver operating characteristic curve of serum miRNA-155 in the diagnosis of HF after MI was 0.941, the cutoff value was 1.77, sensitivity was 92.73%, and specificity was 92.14%. NT-proBNP levels were significantly higher and LVEF was lower in patients with high versus low miRNA-155 expression. Conclusions Patients with HF after MI had elevated miRNA-155 levels and poor cardiac function, suggesting that determining miRNA-155 expression could be used to assess the severity of the disease.


Sign in / Sign up

Export Citation Format

Share Document